Work

Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex

Year: 2017

Type: article

Source: Neuropharmacology

DOI: 10.1016/j.neuropharm.2017.04.023

Authors: D.M. Bortz, H.-Q. Wu, R. Schwarcz, J.P. Bruno

Institutions: The Ohio State University, University of Maryland, Baltimore

Language: English

Topic: Tryptophan and brain disorders

Subfield: Biological Psychiatry

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Public Health Service, National Institute of Mental Health

Awards: Kynurenic Acid and Cognitive Abnormalities in Schizophrenia, Endogenous Kynurenic Acid Modulates Prefrontal ACh Levels and Cognitive Behavior, G5859966921, G8802507182

OpenAlex ID: W2605574980

FWCI: 1.482

Cites: 59

Cited by: 43

Related to: 10